Health Trials

Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Pharmacokinetic Study of Buagafuran Capsules in Participants With Hepatic Impairment and Normal Hepatic Function

This study adopts a non-randomized, open label, parallel, single-dose design to evaluate the safety and pharmacokinetic characteristics of Buagafuran capsules in participants with hepatic impairment.

Participants needed: 24
Trial details
Phase: Phase 1Age: 18-70Biological sex: AllType: InterventionalSponsor: Beijing Union Pharmaceutical Factory LtdUpdated: Mar 10, 2026Locations: 1
Eligibility criteria

Voluntarily sign an informed consent form before the start of activities related... [+6]

Allergic constitution, including individuals with a history of severe drug aller... [+23]

Read more
Status: Not yet recruiting

Study on the Drug Interaction Between Buagafuran and Voriconazole

This study is a non-randomized, open label trial aimed at evaluating the drug interaction between Buagafuran capsules and voriconazole tablets in Chinese adult healthy participants.The research period is 7 days in total.

Participants needed: 18
Trial details
Phase: Phase 1Age: 18-45Biological sex: AllType: InterventionalSponsor: Beijing Union Pharmaceutical Factory LtdUpdated: Mar 9, 2026Locations: 1
Eligibility criteria

Voluntarily sign an informed consent form before the start of activities related... [+4]

Screening period physical examination, vital sign examination, 12 lead electroca... [+19]

Read more
Status: Recruiting

Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD

A placebo-controlled superiority design was used to evaluate the efficacy of 60-120 mg/ day of Buagafuran capsules in the treatment of GAD.

Participants needed: 410
Trial details
Phase: Phase 3Age: 18-65Biological sex: AllType: InterventionalSponsor: Beijing Union Pharmaceutical Factory LtdUpdated: Feb 6, 2024Locations: 1
Eligibility criteria

Outpatients aged 18-65 years old, of both sexes; [+4]

Patients with serious suicide risk at present, or HAMD-17 item 3-suicide score ≥... [+23]

Read more
Status: Recruiting

Phase 3 Clinical Trial of Buagafuran Capsules in the Treatment of GAD

A placebo-controlled superiority design was used to evaluate the efficacy of 60 mg/ day or 120 mg/ day of Buagafuran capsules in the treatment of GAD

Participants needed: 504
Trial details
Phase: Phase 3Age: 18-65Biological sex: AllType: InterventionalSponsor: Beijing Union Pharmaceutical Factory LtdUpdated: Feb 6, 2024Locations: 1
Eligibility criteria

Outpatients aged 18-65 years old, of both sexes; [+4]

Patients with serious suicide risk at present, or HAMD-17 item 3-suicide score ≥... [+23]

Read more